Diana Ibrahim Email & Phone Number | Experienced in Immunology & Oncology with an established track record in developing therapeutic products from the pre-clinical stage through registrational. My experience includes 5+ years of combined Clinical Operations, Logistics, and Regulatory Affairs. In 2017, I began my career in the clinical field enrolling patients into gene therapy trials. I later pursued the biopharma industry where I have successfully managed the logistics of patient enrollment into multiple trials, supported high-quality regulatory submissions for INDs, BLAs, and supplemental BLAs, and have assisted with GCP inspections following marketing authorization applications.

Diana Ibrahim

Experienced in Immunology & Oncology with an established track record in developing therapeutic prod...
Santa Monica, California, United States

*50 free lookup(s) per month.

Diana Ibrahim’s Phone Numbers

Get DIANA’s Phone Number (For Free)

Social Media

Diana Ibrahim’s Location Santa Monica, California, United States

Diana Ibrahim’s Current Industry Neogene Therapeutics

Diana Ibrahim’s Prior Industry Instil Bio | Kite Pharma | Fred Hutch

Find accurate emails & phone numbers for over 700M professionals.

Sr. Manager, Regulatory Affairs

2023-02-01 00:00:00 - Present

Manager, Regulatory Affairs

2021-05-01 00:00:00 - 2023-02-01 00:00:00

Manager, Regulatory Affairs

2021-03-01 00:00:00 - 2021-05-01 00:00:00

Clinical Research Coordinator II - Department of Immunology and Oncology

2017-03-01 00:00:00 - 2018-06-01 00:00:00

No Skills Available

No Languages Available

Diana Ibrahim is a Experienced in Immunology & Oncology with an established track record in developing therapeutic products from the pre-clinical stage through registrational. My experience includes 5+ years of combined Clinical Operations, Logistics, and Regulatory Affairs. In 2017, I began my career in the clinical field enrolling patients into gene therapy trials. I later pursued the biopharma industry where I have successfully managed the logistics of patient enrollment into multiple trials, supported high-quality regulatory submissions for INDs, BLAs, and supplemental BLAs, and have assisted with GCP inspections following marketing authorization applications.